You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】阿里急插7%無力彈 美團低開7%後大拗腰、資金即市開熊 恆指牛69790 熊58816/ 阿里購19133 沽17098/ 美團牛53945 熊69864
阿思達克 11-11 10:31
市場繼續憧憬新冠肺炎疫苗面世利好經濟,道指隔晚收報29420點,升262點(或0.9%),但納指連日下挫。恆指昨收報26301點,升285點(或1.1%),盤中高見26474點,4個交易日累漲逾1400點(或5.7%)。今早跌數十點,回至26200點水平。恆指好倉(牛證及認購權證)昨淨流出逾7900萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾1.4億元,反映投資者預期港股連升過後將回軟。昨日恆指牛證街貨重貨區為收回價24900至24999點,而熊證街貨重貨區為收回價26500至26599點。

內地擬出台平台經濟領域的反壟斷指南,重磅科網股大幅低開。

阿里巴巴(09988)低開7.4%,其後續於255元附近徘徊。昨日阿里好倉錄得逾1.3億元淨流入,5日合共淨流入超過1.8億元,為期間個股好淡倉項目中最多資金淨流入,淡倉昨日淨流出760萬元,

新冠肺炎疫苗成效顯著的消息,加上內地擬加強規管平台經濟壟斷情況,令資金流出新經濟股,相關股份應聲急挫。美團(03690)昨大成交下挫10.5%收市,險守300元關,盤中曾跌至289元,幾乎蒸發月內升幅,同時錄近17億元北水淨流出。市場認為美團繼續是今周五恆指季檢的染藍熱門,但股份今早低開6%,低見282元,其後跌幅顯著收窄至不足1%。輪證資金流方面,逾1.6億元淨流入其好倉,為上日最多資金淨流入的個股好淡倉項目,淡倉同日則有近2200萬元淨流出。

即將公布季度業績的京東(09618),公布雙11促銷活動期間累計下單金額突破2000億元人民幣。不過受資金換馬影響,京東昨亦要下挫8.7%收市,報330.4元,盤中低見323元,連失10天和20天線。股份今早一度再瀉逾6%,低位跌穿310元。逾6500萬元於昨日淨流入其好倉,淡倉同日則有逾290萬元淨流出。

平安好醫生(01833)是昨日跌幅相對溫和的新經濟股,儘管盤中曾跌穿99元,尾市仍能重返百元關,收報100.5元,跌2.8%,回落至10天和20天線以下。公司公布成立互聯網眼科中心,為旗下首個互聯網醫療專科中心。股份今早跌近3%,低位穿98元,暫錄四連跌。昨有逾10萬元淨流入其好倉,淡倉同日亦有逾30萬元淨流入。

新冠疫苗消息令傳統經濟股走高,上季EBITDA按季虧損收窄的銀娛(00027),昨高開在65元,創52周高並是全日最高位,最終收升4.0%於61.25元。今早先升後回,升抵63元後倒跌,考驗60元關口支持。有券商預測澳門11月賭收按年下跌78%。昨有逾560萬元淨流出其好倉,淡倉同日則有逾220萬元淨流入。

瑞通相關認股證之選擇:

阿里價外、中短期購19133,行使價:309.28元,2021年4月到期,實際槓桿:6.3倍

阿里輕微價外、短期沽17098,行使價:239.9元,2021年2月到期,實際槓桿:5.9倍

美團輕微價外、中短期購25361,行使價:326.88元,2021年3月到期,實際槓桿:5.2倍

美團價外、中短期沽25355,行使價:236元,2021年2月到期,實際槓桿:5.8倍

京東輕微價外、短期購25051,行使價:339.98元,2021年1月到期,實際槓桿:7.8倍

京東輕微價外、中短期沽25053,行使價:266.18元,2021年2月到期,實際槓桿:5.3倍

銀河貼價、中短期購28868,行使價:63.88元,2021年2月到期,實際槓桿:7倍

銀河價外、中短期沽23705,行使價:48.8元,2021年2月到期,實際槓桿:8.1倍

騰訊輕微價外、短期購15475,行使價:640元,2021年1月到期,實際槓桿:10.5倍

騰訊輕微價外、短期沽16851,行使價:509.9元,2021年2月到期,實際槓桿:8.2倍

瑞通相關牛熊證之選擇:

恆指牛證69790,收回價:25695點,槓桿比率:32.5倍

恆指熊證58816,收回價:26890點,槓桿比率:35.6倍

阿里牛證65876,收回價:238.99元,槓桿比率:12.1倍

阿里熊證59732,收回價:304.28元,槓桿比率:5.1倍

美團牛證53945,收回價:271.18元,槓桿比率:10倍

美團熊證69864,收回價:339.88元,槓桿比率:5.8倍

銀河牛證64539,收回價:48.18元,槓桿比率:4.2倍

銀河熊證67586,收回價:65.88元,槓桿比率:9.2倍

平醫牛證50788,收回價:92.18元,槓桿比率:10.5倍

小米牛證54944,收回價:21.799元,槓桿比率:8.9倍

小米熊證50466,收回價:27.99元,槓桿比率:5.1倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account